GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EUDA Health Holdings Ltd (NAS:EUDA) » Definitions » Peter Lynch Fair Value

EUDA Health Holdings (EUDA Health Holdings) Peter Lynch Fair Value : N/A (As of May. 25, 2024)


View and export this data going back to 2022. Start your Free Trial

What is EUDA Health Holdings Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for EUDA Health Holdings's Peter Lynch Fair Value or its related term are showing as below:



EUDA's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.34
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


EUDA Health Holdings Peter Lynch Fair Value Historical Data

The historical data trend for EUDA Health Holdings's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EUDA Health Holdings Peter Lynch Fair Value Chart

EUDA Health Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
- - - -

EUDA Health Holdings Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of EUDA Health Holdings's Peter Lynch Fair Value

For the Health Information Services subindustry, EUDA Health Holdings's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EUDA Health Holdings's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EUDA Health Holdings's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where EUDA Health Holdings's Price-to-Peter-Lynch-Fair-Value falls into.



EUDA Health Holdings Peter Lynch Fair Value Calculation

EUDA Health Holdings's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *-0.17
=N/A

EUDA Health Holdings's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $-0.17.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


EUDA Health Holdings  (NAS:EUDA) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

EUDA Health Holdings's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=2.335/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EUDA Health Holdings Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of EUDA Health Holdings's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


EUDA Health Holdings (EUDA Health Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1 Pemimpin Drive No. 12-07, One Pemimpin, Singapore, SGP, 576151
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.
Executives
Kongyew Wong director C/O 6 EU TONG SEN STREET, #08-13, THE CENTRAL U0 059817
Chen Wei Wen Kelvin director, officer: CHIEF EXECUTIVE OFFICER C/O 1 PEMIMPIN DRIVE #12-07,, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Alfred Lim director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151
Kim Hing Chan director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
David Francis Capes director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Daniel Tan officer: CHIEF TECHNOLOGY OFFICER C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Steven John Sobak officer: CHIEF FINANCIAL OFFICER C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Lim Thien Su Gerald director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151
Tan Meng Dong (james) director, 10 percent owner, officer: Chief Executive Officer UNIT 2003 KINGKEY 100, TOWER B, 5015 SHENNAN EAST ROAD, LUOHU DISTRICT, SHENZHEN/GUANGDONG F4 518000
Alexander K. Arrow director PO BOX 3094, REDWOOD CITY CA 94064
Kwong Yeow Liew director RM 2313-2315, BLOCK B, ZHONGSHEN GARDEN, SHENZHEN F4 518101
Yap Guan Hong William director, officer: Chief Financial Officer 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817
Ajay Rajpal director 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817
8i Holdings 2 Pte Ltd 10 percent owner C/O 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817